AI assistant
Cibus, Inc. — Director's Dealing 2019
Feb 27, 2019
34396_dirs_2019-02-26_c944b3fd-3f05-4838-aceb-4e6c46d0832a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Calyxt, Inc. (CLXT)
CIK: 0001705843
Period of Report: 2019-02-25
Reporting Person: Voytas Daniel F (Chief Science Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-25 | Common Stock | M | 3977 | $3.59 | Acquired | 96959 | Direct |
| 2019-02-25 | Common Stock | S | 3977 | $16.00 | Disposed | 92982 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-25 | Stock Option (Right to Buy) | $3.59 | M | 3977 | Disposed | 2026-04-07 | Common Stock (3977) | Direct |
Footnotes
F1: Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.
F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.
F3: The stock option to purchase shares of Calyxt, Inc. common stock ("Stock Option") was granted on December 3, 2014 and vested 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vested quarterly in equal installments thereafter, 15% of which vested immediately on July 25, 2017 when Calyxt, Inc. underwent its initial public offering.